-dependent activation of NO production mediates apoptosis after TG exposure in JT/Neo cells. JT/Bcl-2 and JT/Bcl-X L cells are susceptible to NO-mediated apoptosis, but Bcl-2 and Bcl-X L protect the cells against TG-induced apoptosis by negatively regulating Ca 2؉ -sensitive NO synthase activity or expression.
Apoptosis (programmed cell death) is an important physiological process, and when dysregulated, it contributes to the pathogenesis of a variety of diseases including cancer, autoimmunity, and neurodegenerative disorders (22, 61) . Apoptosis results from the action of a genetically encoded suicide program that leads to a series of characteristic morphological and biochemical changes (22, 60, 70) . These changes include activation of caspases, mitochondrial depolarization, loss of cell volume, chromatin condensation, and nucleosomal DNA fragmentation (10, 22, 60, 70) . Among the growing number of genes that are understood to regulate apoptosis is the Bcl-2 family of genes (5, 51, 53) . Some of the proteins within this family, including Bcl-2 and Bcl-X L , inhibit apoptosis, and others, such as Bax and Bak, promote apoptosis and in some instances are sufficient to cause apoptosis independent of additional signals (49, 51, 53) . Bcl-2 and related antiapoptotic proteins appear to act in part by dimerizing with a proapoptotic molecule (e.g., Bax) and interfering with the apoptosis induced by Bax (45, 58) .
Several different biochemical changes have been proposed to be the essential event that commits a cell to undergo apoptosis (46) (47) (48) (49) (50) (51) (52) (53) . These events include the generation of reactive oxygen species (ROS), induction of nitric oxide synthase (NOS), increase in the intracellular calcium level, loss of mitochondrial membrane potential, cytochrome c redistribution, and caspase activation (20, 48, 50, 51, 62, 70) . All of these biochemical perturbations can result from alterations in mitochondrial function (50, 53, 70) . In addition, at least two resident mitochondrial proteins, apoptosis-initiating factor (AIF) and cytochrome c, have been implicated in the activation of caspases (34, 52, 59) .
It has been shown that Bcl-2 and Bcl-X L may regulate ion fluxes (2, 19, 31, 32, 37, 38) . This concept is supported by evidence that Bcl-2 overexpression decreases Ca 2ϩ efflux through the endoplasmic reticulum (ER) membrane following thapsigargin (TG) treatment (19) , prevents Ca 2ϩ redistribution from the ER into the mitochondria following growth factor withdrawal (2) , and inhibits apoptosis-associated Ca 2ϩ waves (31, 37) and nuclear Ca 2ϩ uptake (38) . Bcl-2 overexpression also enhances the uptake of calcium by mitochondria (42, 56) and preserves mitochondrial transmembrane potential (71) . These findings suggest that Bcl-2 might act as a regulator of intracellular Ca 2ϩ concentration through its interaction with the ER and mitochondrial membranes. However, it has been hypothesized that Bcl-2 may heterodimerize with Bax and form pores, similar to those made by bacterial toxins, which can function as channels in the ER and mitochondrial membranes for ions, proteins, or both (50, 51) . With Bcl-2 inducing the closing and Bax stimulating the opening of the pores, the ratio of Bcl-2 to Bax may determine the concentration of Ca 2ϩ released into the cytoplasm (50, 51) . Recent findings provide strong evidence that Bcl-X L also regulates ion fluxes. First, the X-ray and nuclear magnetic resonance spectroscopy structure of Bcl-X L resembles the physical structure of ion channelforming bacterial toxins (41) . Second, Bcl-X L forms an ion channel in synthetic lipid membranes (33, 40) . It has been shown that Bcl-X L forms a cation-selective channel that conducts sodium but not calcium (31) .
Recent evidence suggests that the JNK/SAPK pathway may play an important role in triggering apoptosis in response to inflammatory cytokines (interleukin-1, tumor necrosis factor alpha), free radicals generated by UV and gamma radiation, or direct application of H 2 O 2 (7, 11, 12, 30, 35, 36, 67) . In response to the above cellular stresses, JNK is strongly activated (11, 12) . Overexpression of dominant negative mutants of components in the JNK pathway, such as ASK1(K709R), SEK1(Lys3Arg) (both are upstream kinases), and c-Jun⌬169 (a downstream target), can effectively prevent apoptosis (18, 25, 67, 69) . Furthermore, transfection of the constitutively activated forms of ASK1, SEK1, or c-Jun results in apoptotic cell death (18, 25, 67, 69) .
In the present study, we used TG, an ER Ca 2ϩ -ATPase inhibitor, to disrupt calcium homeostasis. The objectives of this study were to investigate (i) the effect of Bcl-2 and Bcl-X L overexpression on TG-induced intracellular Ca 2ϩ accumulation in Jurkat T lymphocytes and (ii) the intracellular mechanisms mediating TG-induced apoptosis in Jurkat T lymphocytes. Our results indicate that TG-induced apoptosis results from a transient increase of intracellular free calcium levels, calcium-dependent nitric oxide production, cytochrome c redistribution, reduction in mitochondrial membrane potential (⌬⌿ m ), and activation of caspase-3 and the JNK pathway. Overexpression of Bcl-2 and Bcl-X L antagonizes apoptosis early in this pathway by blocking the capacity of cells to generate nitric oxide.
Cells and culture conditions. Jurkat T cells were obtained from the American Type Culture Collection (Rockville, Md.). The cells were cultured at 37°C under 5% CO 2 in RPMI 1640 tissue culture medium (Bio Whittaker Inc., Walkersville, Md.) supplemented with 2 mM L-glutamine, 10% fetal bovine serum, and 1% penicillin-streptomycin mixture. The concentration of calcium in RPMI 1640 medium was 1.4 mM. For short-wavelength UV light (UVC) treatment of cells, the medium was removed and the cells were washed twice with phosphatebuffered saline. The cells were irradiated at a dose rate of 20 or 40 J/m 2 (as described in the figure legends), after which the original culture medium was added back to the cells.
Transfection of Bcl-2 and Bcl-X L genes. Jurkat T lymphocytes (2 ϫ 10 6 ) were transfected with pSFFVneo-Bcl-2, pSFFVneo-Bcl-X L or pSFFV-neo (a gift from Stanley Korsmeyer, Dana-Farber Cancer Institute, Boston, Mass.) with Lipofectin (GIBCO BRL, Grand Island, N.Y.). Transduced cells were selected for 3 weeks in RPMI 1640 medium containing 10% fetal bovine serum and 1 mg of G418 (Geneticin; GIBCO BRL) per ml. The clones expressing the highest levels of Bcl-2 and Bcl-X L were used for this study. Lysates were evaluated for Bcl-2 and Bcl-X L expression by immunoblot analysis.
For transient transfection, Lipofectin reagent was used to transfect cDNA plasmids by following the protocol provided by the manufacturer (GIBCO BRL). After transfection, the cells were incubated with complete medium for one additional day. These cells were then used for experiments.
Calcium measurements. For the measurement of intracellular Ca 2ϩ concentration by flow cytometry, 10 7 cells were loaded for 45 min at 37°C with 5 M indo-1/AM. The cells were washed, resuspended at 10 6 /ml in HBSS containing 1.4 mM CaCl 2 , 10 mM HEPES, and 10% fetal bovine serum, and maintained at 37°C while being run on the flow cytometer. The cells were analyzed on a FACStar
Plus flow cytometer (Becton Dickinson) with a Krypton laser with UV optics for excitation of the indo-1. Optimal Ca 2ϩ -sensitive ratios were obtained by measuring the violet (405-nm) light from calcium-bound dye and blue (485-nm) emitted light from unbound indo-1. The mean ratios were calculated over time by using MultiTime Kinetic Software (Phoenix Flow Systems).
For the measurement of intracellular free Ca 2ϩ with the PTI Deltascan spectrofluorometer (SCAN-1; Photon Technology International), cells were loaded with 5 M indo-1/AM at 37°C for 45 min in a medium comprising 0.14 M NaCl, 3 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 10 mM D-glucose, 1.2 mM NaH 2 PO 4 , 4 mM NaHCO 3 , 4 mM HEPES, and 1 mg of albumin per ml. Following loading, the cells were incubated at 2 ϫ 10 6 cells per ml in the cuvette of a PTI Deltascan spectrofluorometer in the medium described above but with 20 mM sodium HEPES and no HCO 3 Ϫ as buffer. Fluorescence was measured at 400 nm (emission maximum from the Ca 2ϩ -bound form of indo-1) and 473 nm (an isobestic point) (54) .
For the measurement of intracellular Ca 2ϩ by confocal microscopic imaging, cells from each group were attached to glass slides coated with 3-aminopropyltriethoxysilane (Aldrich, St. Louis, Mo.) and loaded with 5 M indo-1/AM for 45 min at 37°C. The cells were washed for at least 45 min with Hanks balanced salt solution containing 1.4 mM CaCl 2 , 10 mM HEPES, and 10% fetal bovine serum and visualized under a microscope in the presence or absence of TG. Calcium was imaged in fields of 75 to 100 cells by using a Zeiss LSM 410 inverted confocal microscope with 351-nm excitation from a UV Ar laser with a 40ϫ/1.2 NA c-APO water immersion lens. Epifluorescence was measured at 400 to 435 nm and 473 to 497 nm on matched photomultipliers, and the ratio of these channels was used to estimate the intracellular Ca 2ϩ concentration from an in vitro Ca 2ϩ calibration curve. For comparison of whole-cell and mitochondrial Ca 2ϩ responses, cells were dually loaded with indo-1/AM (which distributes throughout the cell) and the mitochondrion-localizing Ca 2ϩ indicator rhod-2. The cells were incubated with 5 M rhod-2 for 30 min at 25°C, washed in Hanks balanced salt solution (containing 1.4 mM Ca 2ϩ and 10% fetal bovine serum) for 45 min, and then incubated with indo-1/AM as described above. Cells dually loaded with rhod-2 and indo-1/AM remained in indicator-free medium for at least 3 h before being imaged. This method results in selective mitochondrial loading with rhod-2 (i.e., without significant extramitochondrial loading). This was confirmed in a parallel group of cells by colocalization of rhod-2 fluorescence with that of the mitochondrion-specific probe Mito Tracker Green FM (250 nM for 30 min at 25°C) and by Ͼ95% loss of rhod-2 fluorescence within 5 min after addition of 1 M FCCP to the bath (with no significant change in indo-1/AM fluorescence). Rhod-2 fluorescence was obtained in cells coloaded with indo-1/AM by excitation at 543 nm from a He-Ne laser, measuring the emitted fluorescence with a long-pass 570 nm filter. Rhod-2 fluorescence signals were not calibrated and represent a qualitative measure of changes in mitochondrial Ca 2ϩ . There was no detectable fluorescence cross talk between the rhod-2 and indo-1/AM channels. Every cell within the microscopic field was included in the assessment of Ca 2ϩ . Image processing was performed with MetaMorph (Universal Imaging Corp., West Chester, Pa.) on a Pentium computer.
Measurement of mitochondrial energization. Mitochondrial energization was determined as the retention of the dye 3,3Ј-dihexyloxacarbocyanine (DiOC 6 )(3). Cells (5 ϫ 10 5 in 500 l of complete RPMI 1640 medium) were loaded with 100 nM DiOC 6 (3) during the last 30 min of treatment. The cells were then pelleted at 700 ϫ g for 10 min. The supernatant was removed, and the pellet was resuspended and washed in phosphate-buffered saline (PBS) twice. The pellet was then lysed by the addition of 600 l of deionized water followed by homo-genization. The concentration of retained DiOC 6 (3) was determined on a fluorescence spectrometer (Cyto Fluor; PerSeptive Biosystems, Framingham, Mass.) at 480-nm excitation and 510-nm emission (49) . Subcellular fractionation. Mitochondrial and cytosolic (S100) fractions were prepared by resuspending cells in 0. (20) . The cells were passed through an ice-cold cylinder cell homogenizer. Unlysed cells and nuclei were pelleted by a 10-min centrifugation at 750 ϫ g. The supernatant was centrifuged at 10,000 ϫ g for 25 min. This pellet was resuspended in buffer A and represents the mitochondrial fraction. The supernatant was centrifuged at 100,000 ϫ g for 1 h. The supernatant from this final centrifugation represents the S100 fraction.
Lysate preparation. For determination of JNK activity, cells were collected by centrifugation at 300 ϫ g for 5 min at 4°C. The cell pellets were washed with cold PBS and solubilized with ice-cold JNK lysis buffer (25 mM HEPES [pH 7.5], 300 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.1% Triton X-100, 20 mM ␤-glycerophosphate, 0.1 mM sodium orthovanadate, 0.5 mM DTT, 100 g of phenylmethylsulfonyl fluoride per ml, 2 g of leupeptin per ml). The cellular extract was then centrifuged for 30 min at 1,200 ϫ g to remove debris. The supernatant was used immediately or aliquoted and stored at Ϫ70°C for future use.
For Western blotting, cells were lysed in a buffer containing 10 mM Tris-HCl (pH 7.6), 150 mM NaCl, 0.5 mM EDTA, 1 mM EGTA, 1% sodium dodecyl sulfate (SDS), 1 mM sodium orthovanadate, and a mixture of protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 1 g of pepstatin A per ml, 2 g of aprotinin per ml). The lysates were then sonicated for 10 s and centrifuged for 20 min at 1,200 ϫ g. The supernatants were used to perform SDS-polyacrylamide gel electrophoresis (PAGE) or stored at Ϫ70°C.
Measurement of JNK activity. JNK1 was immunoprecipitated and kinase activity was measured by using an immunokinase complex assay with GST-c-Jun as a substrate as described previously (30) . Briefly, cell lysates (200 g of protein) were first incubated overnight at 4°C with 10 g of polyclonal anti-JNK1 and then incubated with 20 l of Sepharose A-conjugated protein A for an additional 1 h. The beads were pelleted and washed three times with cold PBS containing 1% Nonidet P-40 and 2 mM sodium orthovanadate, once with cold 100 mM Tris-HCl (pH 7.5) buffer containing 0. Measurement of nitric oxide. For the measurement of nitric oxide (NO), the Griess reagent kit (Molecular Probes, Inc.) was used. This assay involves the use of the Griess diazotization reaction to spectrophotometrically detect nitrite formed by the spontaneous oxidation of NO under physiological conditions. The detection limit for this method is between 0.1 and 1.0 M nitrite. Nitrite concentrations were measured in cell lysates.
Western blot analysis. Equal amounts of lysate protein (40 g/lane) were subjected to SDS-PAGE with either 10% or 8 to 16% polyacrylamide gels and electrophoretically transferred to nitrocellulose. Nitrocellulose blots were first blocked with 10% nonfat dry milk in TBST buffer (20 mM Tris-HCl [pH 7.4], 500 mM NaCl, 0.01% Tween 20) and then incubated overnight at 4°C with primary antibody in TBST containing 5% bovine serum albumin. Immunoreactivity was detected by sequential incubation of horseradish peroxidase-conjugated secondary antibody, and specific complexes were detected by the enhanced chemiluminescence technique.
Measurement of caspase-3 activity. ApoAlert caspase assay kit (Clontech Laboratories, Inc., Palo Alto, Calif.) was used to measure caspase-3 activity. The ApoAlert caspase-3 fluorescence assay kit detects the shift in fluorescence emission of 7-amino-4-trifluoromethyl coumarin (AFC). AFC is conjugated to a specific tetrapeptide sequence (DEVD-AFC). Normally the conjugate emits blue light. Upon cleavage of the substrate by protease, the liberated AFC emits a yellow-green fluorescence at 505 nm. Assays were performed directly on crude cell lysates as specified by the manufacturer.
Apoptosis. For detection of apoptotic cells, the cells were first washed twice with cold PBS and then fixed with 4% paraformaldehyde for 30 min. The fixed cells were washed again with PBS and stained with 1 g of DAPI per ml for 30 min. The apoptotic cells were examined under a fluorescence microscope. Cells containing condensed or fragmented nuclei were scored as apoptotic. Data are expressed as a percentage of apoptotic cells in total counted cells.
For detection of apoptosis by annexin V fluorescence and propidium iodide staining, a kit was purchased from R & D Systems. We used the procedure as described by the manufacturer.
Nucleosome ELISA. The nucleosome ELISA allows the quantitation of apoptotic cells in vitro by DNA affinity-mediated capture of free nucleosomes followed by their anti-histone-facilitated detection. In this assay, mono-and oligonucleosomes are captured on precoated DNA-binding proteins. Standards were provided in the kit to measure number of nucleosomes per milliliter. Based on the standard curve, we measured nucleosomes (units per milliliter) in the cell lysates. Cells (2 ϫ 10 6 ) were seeded into 24-well plates for 36 h in the presence or absence of various drugs (see the figure legends). They were harvested for the nucleosome ELISA as specified by the manufacturer (Oncogene Research Products, Cambridge, Mass.). Anti-histone 3 biotin-labeled antibody binds to the histone component of captured nucleosomes and is detected following incubation with streptavidin-linked horseradish peroxidase (SA-HRP) conjugate. HRP catalyzes the conversion of colorless tetramethylbenzidine to blue. The addition of stop solution changes the color to yellow, the intensity of which is proportional to the number of nucleosomes in the sample.
RESULTS
Overexpression of Bcl-2 or Bcl-X L does not alter TG-induced calcium release. Jurkat T lymphocytes were transfected with human Bcl-2 (JT/Bcl-2) or Bcl-X L (JT/Bcl-X L ) to measure the effects of these antiapoptotic genes on TG-induced cytoplasmic calcium accumulation. Transfection of Bcl-2 and Bcl-X L genes in Jurkat T cells resulted in significant overexpression of these proteins (Fig. 1) . Treatment of JT/Neo cells with TG resulted in a transient increase in the intracellular free calcium level that varied in a dose-dependent manner (1 to 100 nM) (data not shown). Overexpression of Bcl-2 or Bcl-X L in Jurkat T cells had no significant effect on the transient increase in the intracellular free calcium level induced by 50 nM TG compared to overexpression of Neo ( Fig. 2A) . Pretreatment of Jurkat cells with BAPTA-AM abrogated the transient increase in intracellular free calcium levels due to TG treatment (data not shown). We further examined the involvement of extracellular calcium in TG-induced transient calcium release by using EGTA (an extracellular calcium chelator), which was added at 2 mM to remove any contribution of extracellular calcium to the 400-nm emission (Fig. 2B ). TG (500 nM) gave a large and transient increase in the 400-nm/473-nm ratio and hence in cytosolic free Ca 2ϩ , reflecting the release of ER Ca 2ϩ into the cytosol (Fig. 2B ). Ionomycin (5 M) addition released Ca 2ϩ from other cellular compartments. Subsequent addition of 8 mM EGTA and 12 mM CaCl 2 gave fluorescence emission ratio minimum (R min ) and maximum (R max ) values, respectively (Fig. 2B) . We next sought to compare the FCCP-(a mitochondrial uncoupler) and TG-releasable Ca 2ϩ stores (Fig. 2C ). Addition of the uncoupling agent FCCP (0.25 M) allowed the mobilization and visualization of the mitochondrial Ca 2ϩ pool (Fig. 2C ). Subsequently added TG (500 nM) gave a large and transient increase in the cytosolic free Ca 2ϩ concentration (Fig. 2C ). These data suggest that intracellular free-Ca 2ϩ store release induced by TG was not affected by extracellular Ca 2ϩ influx.
Since Bcl-2 and Bcl-X L did not block TG-induced transient intracellular free Ca 2ϩ levels in cells, we sought to determine the calcium levels in the mitochondria and cytosol at 3 h (Fig.  3) . At 3 h, overexpression of Bcl-2 or Bcl-X L had no effect on the level of mitochondrial or cytosolic free calcium, which was similarly increased by TG in all cell lines ( Fig. 3A and B) . Further, TG-induced apoptosis was correlated with intracellular calcium levels in excess of 600 nM, which were correspondingly reduced in JT/Bcl-2 and JT/Bcl-X L cells (Fig. 4B ). The elevated Ca 2ϩ levels at 36 h occur at a time when the apoptosis process is ongoing in cells not overexpressing Bcl-2 and Bcl-X L . Thus, the late alterations in Ca 2ϩ levels are a consequence of apoptosis. Early calcium fluxes are not influenced by Bcl-2 and Bcl-X L expression.
A rise in the intracellular calcium level is necessary for TG-induced apoptosis. We first determined the effects of Bcl-2 and Bcl-X L on TG-induced apoptosis (as measured by nucleosome ELISA) over time (Fig. 5A) . Treatment of JT/Neo cells with TG (50 nM) resulted in induction of apoptosis which began after 6 h and increased over a period of 48 h (Fig. 5A) . Overexpression of Bcl-2 or Bcl-X L inhibited TG-induced apoptosis over a period of 48 h (Fig. 5A) . To evaluate the relationship between intracellular calcium levels and apoptosis, we used irreversible (TG) and reversible (CPA) inhibitors of the ER calcium-ATPase pump. These compounds are known to increase intracellular calcium levels. Treatment of wild-type Jurkat cells with TG or CPA resulted in the induction of apoptosis in a dose-dependent manner at 36 h ( Fig. 5B and C) . We next examined the source of the calcium that accumulated after TG or CPA treatment. BAPTA-AM was used to chelate cytoplasmic calcium, and EGTA was used to chelate extracellular calcium. Cells were pretreated with BAPTA-AM (10 M) for 45 min, washed with PBS, and reseeded in culture medium with or without TG or CPA. BAPTA-AM abolished the apop- 3 . Overexpression of Bcl-2 or Bcl-X L has no effect on TG-induced changes in mitochondrial and cytosolic free-calcium levels at 3 h. JT/Neo, JT/ Bcl-2, and JT/Bcl-X L cells were treated with TG (50 nM) for 3 h, loaded with indo-1/AM and rhod-2, and analyzed for mitochondrial (A) and cytosolic free (B) calcium levels by confocal imaging microscopy (see Materials and Methods for details). The data are the means and standard errors. Significant differences (P Ͻ 0.05) among groups were determined by analysis of variance with multiple comparisons by the Student-Neuman Keul test and are indicated by different letters. Histograms denoted by a common letter are not significantly different in group comparisons. Means among groups denoted by dissimilar letters are statistically significant. totic effects of TG or CPA (Fig. 5B and C) . By contrast, the chelation of extracellular calcium with 2 mM EGTA had no significant effect on TG-or CPA-induced apoptosis (data not shown). These data suggest that intracellular free calcium accumulation plays a critical initiating role in TG-or CPA-induced apoptosis.
Because TG and CPA induced apoptosis in Jurkat cells, we next examined the effects of Bcl-2 and Bcl-X L overexpression on TG-or CPA-induced apoptosis ( Fig. 5D and E) . Treatment of Jurkat cells with TG or CPA resulted in the induction of apoptosis in a dose-dependent manner at 36 h. Overexpression of Bcl-2 or Bcl-X L blocks TG-or CPA-induced apoptosis ( Fig.  5D and E) in Jurkat cells. Because Ca 2ϩ release is similar in wild-type and Bcl-2-and Bcl-X L -overexpressing cells, Bcl-2 and Bcl-X L must be blocking apoptosis at a point in the pathway downstream of Ca 2ϩ release. Bcl-2 or Bcl-X L prevents the release of cytochrome c. Mitochondria appear to play an important role in the early events of apoptosis (4) . Both mitochondrial depolarization and the loss of cytochrome c from the mitochondrial intermembrane space have been proposed as early central events in apoptotic cell death (52, 70) . Whether cytochrome c release occurs before the loss of mitochondrial membrane potential or as a result of the loss of inner membrane potential remains controversial (29, 59, 70) . Since the cell survival proteins Bcl-2 and Bcl-X L localize to the outer mitochondrial membrane, the effects of Bcl-2 or Bcl-X L overexpression on cytochrome c redistribution and mitochondrial membrane depolarization in response to TG were investigated.
We next determined the presence of cytochrome c in the cytosolic and mitochondrial fractions of cells treated with TG. The subcellular localization of cytochrome c, which normally resides in the mitochondrial intermembrane space, was first assessed at various times following TG treatment (Fig. 6A) . Treatment of wild-type or JT/Neo Jurkat cells with TG resulted in the release of cytochrome c from the mitochondria in a time-dependent manner (Fig. 6A) . In Jurkat cells, the release of cytochrome c began at 2 h and reached a plateau at 4 h (Fig.  6A) . At 4 h after 100 nM TG treatment, Jurkat cells had not yet undergone apoptosis as measured by DAPI staining (data not shown). We next examined the effects of Bcl-2 and Bcl-X L on the cytochrome c release after 4 h of 100 nM TG treatment (Fig. 6B ). There was no cytochrome c in the cytosol of untreated JT/Neo, JT/Bcl-2, or JT/Bcl-X L cells (Fig. 6B) . When cells were treated with TG (100 nM) for 4 h, cytochrome c was detected in the cytosol of JT/Neo cells (Fig. 6B) . By contrast, cytochrome c was not detected in the cytosol of TG-treated JT/Bcl-2 or JT/Bcl-X L cells (Fig. 6B) . The caspase inhibitor z-VAD-fmk did not block TG-induced cytochrome c release from mitochondria (Fig. 6B) . JT/Bcl-2 and JT/Bcl-X L cells were Ͼ92 to 95% viable after 4 h of TG treatment (data not shown). In contrast to the cytochrome c release, the inner mitochondrial membrane protein cytochrome oxidase remained in the mitochondrial fraction in all cell groups under all conditions tested (Fig. 6B) . Thus, Bcl-2 and Bcl-X L appear to act upstream of mitochondrial cytochrome c release from mitochondria in the prevention of TG-induced apoptosis.
The activation of caspases appears to be essential for the implementation of apoptosis (62) . Bcl-2 and Bcl-X L have recently been proposed to regulate caspase activation (8) . Recent data have shown that cytochrome c is involved in the activation of caspase(s) (63) . Treatment of JT/Neo cells with 100 nM TG resulted in an increase in caspase-3 activity (Fig.  6C ). Bcl-2 or Bcl-X L overexpression blocked caspase-3 activation (Fig. 6C) . To assess the involvement of caspase(s) in TGor CPA-induced apoptosis, we used the caspase inhibitors z-VAD-fmk and z-DEVD-fmk. As shown above, TG or CPA induced apoptosis in Jurkat cells in a dose-dependent manner ( Fig. 5D and E) . In addition, Z-VAD-fmk and z-DEVD-fmk blocked TG-and CPA-induced apoptosis in Jurkat cells (Fig.  6D) . These data are consistent with the hypothesis that the inhibition of cytochrome c release in Bcl-2-and Bcl-X L -overexpressing cells results in a failure to activate caspase-3.
TG causes mitochondrial depolarization that is inhibited by Bcl-2 or Bcl-X L but not by z-DEVD-fmk. Mitochondrial permeability transition (MPT) refers to the regulated opening of a large, nonspecific pore in the inner mitochondrial membrane (4). The MPT causes the loss of the mitochondrial membrane potential (⌬⌿ m ) (44) . The fluorescent dye DiOC 6 (3) localizes to mitochondria, and the MPT reduces the accumulation of DiOC 6 (3) as a consequence of the loss of ⌬⌿ m (66) . Treatment of JT/Neo cells with TG produced a steady decline in ⌬⌿ m (Fig. 7A) . Within 4 h, more than 30% of the dye was lost from the cells (Fig. 7A) . The time-dependent loss of DiOC 6 (3) fluorescence in Jurkat cells due to TG treatment was pre- (Fig. 7A) . Consistent with its inability to prevent the loss of cytochrome c release (Fig. 6B) , the caspase inhibitor z-DEVD-fmk had no effect on TG-induced mitochondrial depolarization (14) (Fig.  7B ). These data suggest that Bcl-2 and Bcl-X L regulate the release of mitochondrial factors that are required for caspase activation, and the caspases act downstream of mitochondrial apoptotic events since the caspase inhibitors have no effect on cytochrome c release and loss of ⌬⌿ m caused by TG. TG activates the JNK/SAPK pathway. Activation of the JNK pathway has been implicated in initiating apoptosis in response to several stimuli (6, 7, 11, 12, 30, 35, 67) . To test the hypoth- 
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on April 30, 2016 by guest http://mcb.asm.org/ esis that TG-induced apoptosis may involve the JNK pathway, we examined the effects of TG, which include JNK activation and the phosphorylation of c-Jun, on this pathway. We first characterized the JNK assay by using wild-type Jurkat cells (Fig. 8) . The kinase activity increased between 0 and 4 h after TG treatment and reached a plateau thereafter (Fig. 8A) . The kinase activity was also increased with the various doses of TG treatment over 3 h (Fig. 8B) . Thus, TGinduced apoptosis includes JNK activation. Based on these results, we used 100 nM TG and 4-h incubation times for further experiments.
Overexpression of Bcl-2 or Bcl-X L blocks JNK/SAPK activation by TG. We next examined the effects of TG on the activation of mitogen-activated protein (MAP) kinases (JNK, ERK, and p38) by using JNK, ERK, and p38 antibodies specific for the phosphorylated and activated forms of these kinases. Western blot analyses revealed that TG (100 nM for 4 h) activated the JNK pathway in JT/Neo cells and that the activation of JNK was blocked in JT/Bcl-2 and JT/Bcl-X L cells (Fig. 9A) . This phospho-specific antibody can recognize both phospho-JNK1 (46 kDa, a lower band) and phospho-JNK2 (54 kDa, a higher band) (Fig. 9A ). The immunoblot with JNK1-specific antibody revealed that the total JNK1 protein level did not change significantly in JT/Neo, JT/Bcl-2, and JT/Bcl-X L cells (Fig. 9A) . Only modest activation of ERK was noted in response to TG (100 nM) treatment, and the level did not differ significantly in JT/Neo, JT/Bcl-2, and JT/Bcl-X L cells (Fig. 9B ). The immunoblot with ERK2-specific antibody revealed that ERK2 protein did not change in JT/Neo, JT/Bcl-2, and JT/Bcl-X L cells (Fig. 9B) . To evaluate the involvement of ERK in TG-induced apoptosis, we used a specific inhibitor of MEK1/2 (PD098059), kinases upstream of ERK1/2. Cells were pretreated with 10 M MEK1/2 inhibitor (PD098059) for 1 h and then incubated with 100 nM TG for 36 h. The ERK inhibitor PD098059 had no effect on TG-induced apoptosis (data not shown), suggesting that the modest activation of ERK is a consequence rather than the cause of TG-induced apoptosis. Interestingly, p38 was not activated in response to 100 nM TG treatment and total p38 levels did not change in JT/Neo, JT/Bcl-2, and JT/Bcl-X L cells (Fig. 9C ). In addition, p38 was activated in response to UV light (UVC) treatment. These data suggest that TG activates the JNK pathway and that TG-induced JNK activation can be blocked by Bcl-2 or Bcl-X L overexpression.
JNK/SAPK signaling mediates TG-induced apoptosis. As mentioned previously, the JNK/SAPK pathway involves an orderly activation of proteins, MEKK1, SEK1, JNK, and c-Jun (11, 12, 25) . SEK1 kinase activates JNK, and c-Jun is the substrate of JNK. We assessed the role of the JNK pathway in TG-induced apoptosis by using a dominant negative SEK1 (Lys3Arg) mutant and a c-Jun dominant negative mutant Flag⌬169.
pEBG-SEK1 (Lys3Arg) is a dominant negative kinase-inactive construct (67) . In U937 cells, its transfection efficiency is about 39% (67) . Expression of SEK1 (Lys3Arg) in U937 cells inhibits ceramide-or H 2 O 2 -induced endogenous JNK activity by 50% and completely inhibits the co-transfected hemagglutinin-tagged JNK (67) . We transiently transfected this GSTtagged SEK1 dominant negative mutant into Jurkat cells. Its expression was detected by anti-GST immunoblotting (data not shown). By cotransfection with pCMV carrying the lacZ gene and staining with 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal), we calculated that the transfection efficiency was about 65 to 70% in Jurkat cells. Overexpression of this SEK-1 (Lys3Arg) mutant inhibited TG (100 nM for 4 h)-induced endogenous JNK activity by 76% compared with the control group (Fig. 10A) . Accordingly, transiently transfected SEK-1 (Lys3Arg) also inhibited TG-induced phosphorylation of JNK1 as detected with the anti-phospho-JNK antibody (Fig.  10A) . Furthermore, the transfection of SEK1 mutant also significantly inhibited apoptosis as measured by DAPI staining (100 nM TG for 36 h). Thus, these observations suggest that SEK1-JNK1-c-Jun activation is involved in TG-induced apoptosis.
Next, we examined the effects of a dominant negative c-Jun mutant, FLAG169, on TG-induced apoptosis. This c-Jun 169 lacks the ability to activate transcription but is still capable of dimerization and binds to DNA (18, 21) . The c-Jun 169 vector is tagged by an 8-amino-acid FLAG epitope in place of NH 2 -terminal 169, allowing its expression to be monitored by Western immunoblotting or immunocytochemistry with monoclonal anti-M2 (18) . We transiently transfected Jurkat cells with this c-Jun 169 and detected its expression by anti-M2 immunoblotting (Fig. 10B) . Its transfection efficiency was about 60 to 70% as determined by both anti-M2 immunocytochemistry and cotransfection with pCMV vector expressing lacZ. One day after transfection, the cells were exposed to 100 nM TG for 36 h. Compared with the situation for empty vector-transfected Jurkat cells, c-Jun 169 effectively reduced TG-induced apoptosis by more than 60% (Fig. 10B) . The transfection of c-Jun 169 itself did not affect cell behavior, since no apoptosis was observed (Fig. 10B ). In accordance with the above data from the negative SEK1 mutant experiments, the data with dominant If the activation of JNK by TG is mediated by an increase in intracellular calcium levels, buffering of cytosolic calcium should block such an activation. Figure 5A showed that TGinduced apoptosis was blocked by the pretreatment of Jurkat cells with BAPTA-AM (10 M). We therefore investigated whether chelation of intracellular calcium by BAPTA-AM would block TG-induced JNK activation (Fig. 10C) . Treatment of Jurkat cells with 100 nM TG for 4 h resulted in the activation of JNK (Fig. 10C) . When cells were pretreated with BAPTA-AM, TG did not cause JNK activation (Fig. 10C) . These results support the idea that the activation and phosphorylation of JNK by TG may be triggered by an increase in cytosolic calcium.
JNK activation occurs in response to changes in mitochondrial functions. We next evaluated whether JNK is activated before or after changes in mitochondrial functions in response to TG treatment. Transfection of a dominant negative SEK1(Lys3Arg) mutant did not block TG-induced cytochrome c release into the cytosol (Fig. 11A) , suggesting that JNK activity is not required for cytochrome c release. This raises a possibility of JNK activation in response to changes in post-mitochondrial events such as caspase activation (47, 68) . Pretreatment of Jurkat cells with the caspase inhibitor z-VADfmk or z-DEVD-fmk blocked TG-induced JNK activation (Fig.  11B) . Thus, JNK activation depends upon prior caspase activation.
Although TG-induced apoptosis may involve multiple mechanisms, recent evidence suggests that generation of nitric oxide due to various stimuli may play an essential role in induction of apoptosis (1, 9, 14) . Given that the TG-induced apoptosis is mediated by the JNK pathway (Fig. 10) , we examined the effects of nitric oxide on TG-induced JNK activation and subsequent apoptosis. To explore the involvement of nitric oxide in TG-induced JNK activation and apoptosis, we used the NOS inhibitor L-NAME ( Fig. 11C and D) . The cells were first treated with L-NAME (10 mM) or D-NMMA (an arginine analogue that does not block NOS) (10 mM) or left untreated (control) for 45 min. These cells were then exposed to 100 nM TG for either 4 or 36 h to determine JNK activity and apoptotic cell death, respectively. Pretreatment of Jurkat cells with L-NAME inhibited TG-induced JNK activation and apoptosis ( Fig. 11C and D) . The inactive D-NMMA had no effect on TG-induced JNK activation and apoptosis ( Fig. 11C and D) . Thus, a NOS inhibitor protects against TG-induced apoptosis and prevents JNK activation, providing another piece of evidence for an essential role of JNK activation via NO in TGinduced apoptosis.
Bcl-2 and Bcl-X L do not alter the nitric oxide sensitivity of Jurkat cells, but block the ability to generate nitric oxide in response to TG treatment. Since L-NAME blocked TG-induced apoptosis, we reasoned that NO was essential to the process. To assess whether Bcl-2 and Bcl-X L were protecting the cells against NO-mediated toxicity, we exposed all these cell lines, JT/Neo, JT/Bcl-2, and JT/Bcl-X L , to the NO donor compound SNAP, which generates NO extracellularly in the culture medium, with or without added TG. As shown in Fig.  12A , TG induces apoptosis of JT/Neo but not JT/Bcl-2 or JT/Bcl-X L cells; however, SNAP is toxic to all three cell lines. The level of SNAP sensitivity is not greatly affected by TG. Thus, the overexpression of Bcl-2 and Bcl-X L does not influence the ability of the cells to survive NO exposure.
There were no differences among the cell lines in NO sensitivity or in Ca 2ϩ release as a consequence of TG. Therefore, we sought to examine nitric oxide production by JT/Neo, JT/ Bcl-2, and JT/Bcl-X L cells exposed to TG (Fig. 12B) . Nitric oxide concentration was assessed by measuring the nitrite concentration in cells at 1, 2, and 6 h by the Griess assay. Treatment of cells with TG resulted in nitrite production as early as 1 h, and the level of nitrite increased over a period of 6 h (Fig.  12B) . As expected, L-NAME (10 mM) and BAPTA-AM (10 M) blocked TG-induced nitrite production in JT/Neo, JT/ Bcl-2, and JT/Bcl-X L cells at 1, 2, and 6 h. The overexpression of Bcl-2 or Bcl-X L inhibited TG-induced nitrite production (Fig. 12B) . The inactive inhibitor of NOS, D-NMMA, had no effect on TG-induced nitrite production. The extracellular nitric oxide donor, SNAP, increased nitrite levels 2.5-to 3-fold in JT/Neo cells. Overexpression of Bcl-2 or Bcl-X L had no effect on SNAP-induced nitrite production. These results suggest that Bcl-2 and Bcl-X L can block the calcium-induced endogenous production of nitric oxide by TG and that the prevention of NO generation is the mechanism by which these proteins protect cells from TG-induced apoptosis.
DISCUSSION
In this paper, we demonstrate that TG induces apoptosis through a pathway involving an increase in intracellular calcium levels, generation of nitric oxide, a reduction in mitochondrial membrane potential, release of mitochondrial cytochrome c, and activation of caspase-3 and the JNK pathway. We also present evidence that overexpression of Bcl-2 or Bcl-X L in Jurkat T lymphocytes had no significant effect on the TG-induced mitochondrial and intracellular free calcium levels up to 3 h. The amplitude of intracellular Ca 2ϩ transiently induced by TG was not affected by the presence or absence of extracellular Ca 2ϩ , indicating that TG must be acting to release intracellular Ca 2ϩ stores. The data suggest that apoptosis is a consequence of the increase in calcium level because preventing the increase directly by chelating intracellular calcium prevents apoptosis. TG induces nitric oxide production and JNK activation, both of which precede apoptosis. The JNK activation increases after 2 h of treatment with TG, whereas apoptotic cells begin to appear after 8 h of exposure of the cells to TG. TG-induced activation of the JNK pathway tightly correlates with the subsequent apoptosis in a concentration-dependent manner. In addition, a dominant negative SEK1 mutant can block TG-induced JNK activation and subsequent phosphorylation of c-Jun as well as apoptosis. Consistent with this result, a dominant negative c-Jun mutant, which blocks c-Jun activation, also inhibits apoptotic cell death by TG. Finally, overexpression of Bcl-2 or Bcl-X L blocks production of nitric oxide, release of cytochrome c, reduction in ⌬⌿ m , and activation of caspase-3 and the JNK pathway in Jurkat cells treated with TG. Thus, our data suggest a model by which TG causes increased intracellular Ca 2ϩ levels, leading to generation of nitric oxide. The nitric oxide then leads to the release of cytochrome c from the mitochondria and a reduction in ⌬⌿ m . The cytochrome c results in activation of caspase-3, and caspase-3 activates the JNK pathway, resulting in apoptosis (Fig. 13) . Blocking any of the steps, calcium release (BAPTA-AM), nitric oxide production (L-NAME and, for the first time, Bcl-2 and Bcl-X L ), caspase activation (z-VAD-fmk, z-DEVDfmk), or JNK activation (dominant negative SEK-1 and c-Jun) blocks the TG-induced apoptosis.
In contrast to our findings, it has been reported that Bcl-2 overexpression attenuates the transient Ca 2ϩ release in response to TG treatment (19, 31) . The ER membrane channel through which Ca 2ϩ flows after TG treatment has not been identified but appears to be distinct from the Ca 2ϩ release channel associated with the inositol 1,4,5-triphosphate receptor (3, 56) . Identification of ion channels associated with the ER membrane may be a requisite for fully understanding the mechanism of action of Bcl-2. He et al. (19) proposed that Bcl-2 may facilitate Ca 2ϩ reuptake in the ER by forming pores when the Ca 2ϩ -ATPase is inhibited by TG. Since Bcl-2 and Bcl-X L are also localized to the mitochondrial membrane, mitochondria may play a role in calcium homeostasis (22, 24, 31) and free radical scavenging and antioxidant activity (23, 26, 55, 71) . These activities might be cooperative, in light of the relationship between oxidant stress and calcium release leading to apoptosis. In the present study, Bcl-2 and Bcl-X L overexpression had no effect on mitochondrial and intracellular free calcium levels up to 3 h after TG treatment. However, these proteins affected the generation of nitric oxide as a consequence of calcium release and thereby prevented downstream events including the release of cytochrome c from the mitochondria and activation of caspase-3 after TG treatment. If Bcl-2 and Bcl-X L have an influence on calcium flux, we could not detect it.
Our results indicate that TG induces a persistent activation of the JNK enzyme, which may play a critical role in the apoptotic suicide program. TG strongly stimulates JNK activity after a 4-h exposure of cells, and the kinase activity persists throughout apoptosis. The sustained JNK activation is Ca 2ϩ dependent and may serve as a death signal in TG-induced apoptosis. Chelation of intracellular calcium with BAPTA-AM prevented the TG-induced JNK activation and apoptosis, confirming the early mediating role of calcium during TG-induced apoptosis. The lag time between the calcium signal and the activation of JNK is consistent with a role for calcium as an upstream activator of JNK. In agreement with this view, a similar longer stimulation of the JNK enzyme was also observed in some environmental stress-induced forms of apoptosis. For example, exposure of Jurkat cells to lethal doses of ␥ and UVC radiation rapidly increases JNK activity after 30 min, FIG. 13. Model showing that disruption of calcium homeostasis leads to apoptosis by altering mitochondrial functions and inducing JNK activation. Disruption of calcium homeostasis by TG increases the intracellular free calcium level and promotes nitric oxide generation in the mitochondria and loss in mitochondrial membrane potential, leading to cytochrome c release, caspase-3 activation, induction of JNK activity, and apoptosis. Overexpression of Bcl-2 or Bcl-X L has no effect on the transient intracellular calcium levels but inhibits nitric oxide production, reduction in ⌬⌿ m , and cytochrome c release, leading to caspase-3 activation and apoptosis. and the activation can last at least 12 h without having a significant effect on p38 MAP kinase and ERK activity (6, 7) . Withdrawal of NGF from differentiated PC12 neuronal cells results in persistent activation of JNK and p38 MAP kinase with inhibition of ERK activity (69) . Although there are variable effects on p38 MAP kinase and ERK activities in different cell systems, the JNK activation is persistent and shows a direct correlation with apoptosis. Furthermore, repression of JNK activation by transfection of a dominant negative mutant, JNK1, prevents ␥ and UVC irradiation-induced apoptosis (6, 7) . Overexpression of a dominant negative mutant of upstream kinase MEK kinase 1 (MEKK1) for JNK inhibits apoptosis induced by deprivation of NGF from differentiated PC12 cells (69) . In the present study, transfection of a dominant negative mutant of SEK, an upstream kinase for JNK, also blocks TGinduced apoptosis. All of these observations indicate that sustained JNK activation is essential to induce apoptosis in some types of cell death. The TG-induced persistent JNK activation may be produced by the continued stimulation of upstream activators of the JNK pathway due to cellular damage by ROS or nitric oxide (13) . An alternative pathway for prolonged JNK activation by TG may be the inactivation of a dual-specificity phosphatase, an enzyme that can dephosphorylate JNK and ERK, resulting in down-regulation of the activities (35) .
Nitric oxide (NO) is an important pleiotropic molecule involved in neurotransmission, regulation of vascular homeostasis, and effector functions of macrophages and endothelial cells (43) . NO is derived from the oxidation of L-arginine catalyzed by constitutive (cNOS) or inducible (iNOS) NO synthase. The cytotoxic effects of NO were found to be associated with apoptosis in normal cells (1, 14) and tumor cells (15, (63) (64) (65) . The mitochondria generate a significant amount of NO, whose production may affect energy metabolism, O 2 consumption, and O 2 free radical formation (16) . The activity of mitochondrial NOS is stimulated when Ca 2ϩ is taken up by mitochondria (17) . In the present study, the activation of JNK is related to the activation of NOS since treatment of cells with the NOS inhibitor L-NAME blocks TG-induced JNK activation and apoptosis.
Bcl-2 is intracellularly located in the places where ROS are generated, such as mitochondria, ER, and nuclear membranes (23) . Bcl-2 inhibits ROS-induced apoptosis through regulation of an antioxidation pathway (22, 23) . There is a complex interrelationship between oxygen radical damage and intracellular Ca 2ϩ fluxes, including evidence that oxidative damage can mobilize Ca 2ϩ from intracellular pools located in the ER and mitochondria (46, 50, 72) . Therefore, it is interesting to speculate that the effects of Bcl-2 on intracellular Ca 2ϩ homeostasis and oxygen radical damage may be related. Reducing Bcl-2 expression with an antisense oligonucleotide increases the sensitivity of the CATH.a cell line to the toxic effects of dopamine (39) . Moreover, overexpression of Bcl-2 in PC12 cells can block JNK activation induced by serum deprivation (48) . It is not known whether NO plays a role in these systems.
The activation of cysteine proteases from the caspase family appears to be essential for apoptosis to occur (62) . These enzymes cleave their substrate(s) after certain recognition sequences ending with an aspartate residue. At least 13 of these enzymes are known, and they seem to cleave with different substrate specificities (62) . Recently, it has been shown that activated caspase-3 (activated by genotoxin) can cleave MEKK1 into an active 91-kDa kinase fragment (68) . A mutant MEKK1 that is resistant to caspase cleavage can block genotoxin-induced apoptosis (68) . In addition, caspase-3-like activity is essential for calphostin c-induced activation of JNK and p38 kinase (47) . Similarly in the present study, caspase inhibitors (z-DEVD-fmk and z-VAD-fmk) were able to block TGinduced JNK activity and apoptosis, suggesting the requirement for caspase activity in JNK activation. Moreover, treatment of Jurkat cells with TG resulted in the activation of caspase-3, and this activation was blocked by Bcl-2, Bcl-X L , or caspase inhibitors.
Alterations in mitochondrial function, in particular the induction of the MPT, are proposed to play a critical role in apoptosis (44) . Cytochrome c release and mitochondrial membrane depolarization as a result of the opening of permeability transition pores have been proposed as early irreversible events during apoptosis (71) . Opening of the MPT pores might mark a point of no return during the effector phase of ongoing apoptosis. Production of nitric oxide in the mitochondria results in mitochondrial lipid degradation and cytochrome c release (60, 61, 64) . Generation of the nitric oxide may be the important event in the mitochondria for the release of cytochrome c, which has been found to activate caspases (28, 29, 70) . Consistent with these findings, microinjection of cytochrome c results in apoptosis (73) that cannot be inhibited by Bcl-X L expression (27) . In addition, at least one mitochondrial protein (AIF) released following mitochondrial depolarization is an activator of nuclear apoptosis, presumably through caspase activation (59) . In a recent report, the induction of the overexpression of Bax in stably transfected Jurkat cells induced MPT, an event that is accompanied by typical features of apoptosis, namely, cytosolic accumulation of cytochrome c, caspase activation, cleavage of poly(ADP-ribose) polymerase, DNA fragmentation, and cell death (49) . Bcl-2 and Bcl-X L block apoptosis by preventing cytochrome c release to the cytosol, downstream caspase activation, reduction in ⌬⌿ m , and AIF liberation (5, 8, 20, 28, 29, 58, 59, 69) . Thus, both the loss of outer mitochondrial membrane integrity leading to cytochrome c release and inner membrane depolarization are caspase-activating events that trigger the apoptotic cascade downstream of Bcl-2 and Bcl-X L .
In conclusion, we have presented data to show that overexpression of Bcl-2 or Bcl-X L in Jurkat T cells attenuated TGinduced nitric oxide production and apoptosis, a process that requires the activation of caspase-3 and the JNK pathway (Fig.  13) . TG-induced apoptosis occurs in a time-and concentration-dependent manner. Corresponding to its proapoptotic action, TG activates the JNK pathway (as indicated by stimulation of JNK and phosphorylation of c-Jun), which occurs before activation of a cell suicide program. A dominant negative mutant SEK1(Lys3Arg) blocks TG-induced JNK activation and subsequent apoptosis. The c-Jun-negative mutant also prevents TG-induced apoptosis. TG-induced apoptosis was caused by a calcium-dependent induction of nitric oxide production. In this system, the antiapoptotic gene products Bcl-2 and Bcl-X L functioned to prevent apoptosis by blocking the calcium-dependent nitric oxide generation. How these proteins affect NOS activity or expression and whether this mechanism accounts for Bcl-2 and Bcl-X L effects in other systems are under investigation.
